NEURACEQ Trademark

Trademark Overview

On Thursday, May 23, 2013, a trademark application was filed for NEURACEQ with the United States Patent and Trademark Office. The USPTO has given the NEURACEQ trademark a serial number of 85940455. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, September 20, 2021. This trademark is owned by Piramal Imaging S.A.. The NEURACEQ trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases
neuraceq

General Information

Serial Number85940455
Word MarkNEURACEQ
Filing DateThursday, May 23, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, September 20, 2021
Registration Number4822567
Registration DateTuesday, September 29, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2014

Trademark Statements

Goods and ServicesDiagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 4, 2013
Primary Code005
First Use Anywhere DateTuesday, July 22, 2014
First Use In Commerce DateFriday, August 1, 2014

Trademark Owner History

Party NameLIFE MOLECULAR IMAGING LIMITED
Party Type32 - New Owner After Registration
Legal Entity Type11 - Company
AddressFareham, Hampshire PO155TT
GB
Party NameLIFE MOLECULAR IMAGING SA
Party Type31 - New Owner After Registration
Legal Entity Type33 - NOT AVAILABLE
AddressMATRAN 1753
CH
Party NamePiramal Imaging S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMatran 1753
CH
Party NamePiramal Imaging S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMatran 1753
CH
Party NamePiramal Imaging S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMatran 1753
CH

Trademark Events

Event DateEvent Description
Tuesday, June 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2013ASSIGNED TO EXAMINER
Wednesday, September 11, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 27, 2013NEW APPLICATION ENTERED
Wednesday, September 11, 2013SUSPENSION LETTER WRITTEN
Wednesday, September 11, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, April 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 14, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 3, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 29, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 2, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 25, 2014ASSIGNED TO LIE
Monday, March 31, 2014SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, May 1, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 3, 2014PUBLISHED FOR OPPOSITION
Thursday, January 29, 2015SOU EXTENSION 1 FILED
Monday, March 2, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, April 30, 2015NOTICE OF REVIVAL - E-MAILED
Tuesday, June 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 11, 2015SOU EXTENSION 1 GRANTED
Friday, June 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2015UNDELIVERABLE MAIL - NO ACTION TAKEN
Thursday, April 30, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 30, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 30, 2015TEAS PETITION TO REVIVE RECEIVED
Thursday, April 30, 2015PETITION TO REVIVE-GRANTED
Thursday, April 30, 2015SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, July 21, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, July 21, 2015USE AMENDMENT FILED
Friday, July 31, 2015STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 22, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 29, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 7, 2021TEAS SECTION 8 & 15 RECEIVED
Friday, August 21, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 29, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, May 27, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, September 20, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, September 19, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 20, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 25, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, September 29, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 19, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

neuraceq diagnostic medical preparations agents radiopharmaceutical scanning neurodegenerative amyloid diseases diagnosis